(Q34033236)

30 July 2017

1 reference

title

Hepatosplenic candidiasis. A manifestation of chronic disseminated candidiasis (English)

1 reference

30 July 2017

1 reference

Kontoyiannis DP

1

1 reference

30 July 2017

Luna MA

series ordinal

2

1 reference

30 July 2017

Samuels BI

series ordinal

3

1 reference

30 July 2017

Bodey GP

series ordinal

4

1 reference

30 July 2017

publication date

1 September 2000

1 reference

Infectious Disease Clinics of North America

30 July 2017

published in

1 reference

30 July 2017

volume

14

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

721-739

1 reference

Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Diagnostic laparoscopy in patients with acute leukemia and suspected hepatic candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Hepatosplenic yeast infection in patients with acute leukemia: a diagnostic problem.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Chronic systemic candidiasis in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Disseminated candidiasis in patients with acute leukemia: two diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Chronic systemic candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Hypersplenism due to disseminated candidiasis in a patient with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Fungal infections complicating acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Hepatosplenic candidiasis in children with cancer. Three cases in leukemic children and a literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Distribution and activity of amphotericin B in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Risk factors for hepatosplenic abscesses in patients with acute leukemia receiving empiric azole treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Use of abdominal computed tomography for identifying disseminated fungal infection in pediatric cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Antifungal agents: chemotherapeutic targets and immunologic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Successful treatment of disseminated candidiasis resistant to amphotericin B by liposomal amphotericin B: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Ultrasound evaluation of hepatic and splenic microabscesses in the immunocompromised patient: sonographic patterns, differential diagnosis, and follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Hepatic candidiasis: an increasing problem in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

[Treatment of hepatosplenic candidiasis with liposomal amphotericin B in a patient with acute leukemia; a case report of the experience of use of liposomal amphotericin B]

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Diagnosis and treatment of splenic fungal abscesses in the immune-suppressed patient

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Fungal splenic abscess

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Candida hepatitis. Histopathologic diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Early detection of chronic disseminated Candida infection in leukemia patients with febrile neutropenia: value of computer-assisted serial ultrasound documentation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Hepatosplenic candidiasis: successful treatment with fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Moniliasis in acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

The spectrum of hepatic candidiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Treatment of hepatosplenic candidiasis with liposomal-amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Hepatic abscess in cancer patients. Characterization and management

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Fungal infection in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Hepatosplenic candidiasis: wheels within wheels.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Impact of the changing epidemiology of fungal infections in the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Interferon gamma and granulocyte-macrophage colony-stimulating factor for the treatment of hepatosplenic candidosis in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

A TH1-TH2-like switch in candidiasis: new perspectives for therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Hypersplenism due to fungal infection of spleen in a successfully treated patient with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Increased serum concentrations of interleukin-10 in patients with hepatosplenic candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Fungal liver infection in marrow transplant recipients: prevalence at autopsy, predisposing factors, and clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Hepatosplenic fungal disease: diagnostic accuracy and spectrum of appearances on MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Detection of acute and treated lesions of hepatosplenic candidiasis: comparison of dynamic contrast-enhanced CT and MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Hepatosplenic fungal infection: CT and pathologic evaluation after treatment with liposomal amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Focal hepatic candidiasis: a distinct clinical variant of candidiasis in immunocompromised patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Hepatic candidiasis in cancer patients: the evolving picture of the syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Evaluation of single-drug and combination antifungal therapy in an experimental model of candidiasis in rabbits with prolonged neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

The Effect of Prophylactic Fluconazole on the Clinical Spectrum of Fungal Diseases in Bone Marrow Transplant Recipients with Special Attention to Hepatic Candidiasis: An Autopsy Study of 355 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Experimental gastrointestinal and disseminated candidiasis in immunocompromised animals

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Experimental basis for use of fluconazole for preventive or early treatment of disseminated candidiasis in granulocytopenic hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Diagnosis and therapeutic monitoring of invasive candidiasis by rapid enzymatic detection of serum D-arabinitol

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

Successful treatment of hepatosplenic candidiasis through repeated cycles of chemotherapy and neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

High dose cytosine arabinoside is a major risk factor for the development of hepatosplenic candidiasis in patients with leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970128-8

7 January 2021

10.1016/S0891-5520(05)70128-8

Identifiers

DOI

1 reference

30 July 2017

1 reference